Nicorettespray Menthe Verte (Nicotine)

Nicotine, the active ingredient in Nicorettespray Menthe Verte, is a nicotine replacement therapy presented as an oromucosal spray for oromucosal use. It helps adults who smoke to manage nicotine withdrawal symptoms and reduce cravings during smoking cessation attempts effectively.

GNH USA supplies Nicorettespray Menthe Verte as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution, with a focus on product integrity, regulatory compliance, and timely delivery to meet the needs of healthcare providers across multiple regions.

Nicotine delivered via an oromucosal spray is used in nicotine replacement therapy to support smoking cessation.

- Smoking cessation: helps smokers reduce cravings and gradually wean off nicotine. - Nicotine withdrawal: provides relief from withdrawal symptoms such as irritability and anxiety. - Relapse prevention: supports maintaining abstinence after quitting.

Common Side Effects: - Mouth irritation or tingling - Throat discomfort - Cough or hoarseness - Nausea or upset stomach - Headache - Dizziness

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, anaphylaxis) - Cardiovascular events (palpitations, arrhythmia, hypertension) - Severe hypotension - Respiratory depression - Seizures - Persistent vomiting

Precautions should be observed when using Nicorettespray Menthe Verte. - Cardiovascular assessment: evaluate patients with recent heart disease before use. - Age restriction: intended for adult smokers only. - Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously. - Pregnancy and lactation: consult a healthcare professional before use. - Child safety: keep out of reach of children and pets. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Potential drug interactions may affect safety or efficacy.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Other nicotine‑containing products: risk of nicotine overdose. - Seizure‑threshold‑lowering drugs: may exacerbate seizure risk.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: nicotine may counteract blood‑pressure‑lowering effects. - Caffeine‑containing medications: possible increase in stimulant effects. - Theophylline: nicotine may alter metabolism, requiring monitoring.